Stay updated on Enfortumab Vedotin in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.

Latest updates to the Enfortumab Vedotin in Solid Tumors Clinical Trial page
- ChecktodayChange DetectedThe page now shows revision v3.5.5 instead of v3.5.4, indicating a newer version of the document. This update does not modify study details, eligibility criteria, or how the page operates.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a new version of the page's documentation. This change does not modify the public content or user-facing features.SummaryDifference0.0%

- Check43 days agoChange DetectedThe study’s listed results/measurement section has been updated, including endpoint time frames and the detailed wording of response and survival measures for cohorts 1–8 and cohort 9. It also reflects newer results posting/submission dates and study-document metadata updates rather than new study design elements like interventions, eligibility, or locations.SummaryDifference3%

- Check79 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check93 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check101 days agoChange DetectedThe status changed from 'No Results Posted' to 'Results Submitted', indicating that results are being prepared/uploaded for the study record.SummaryDifference0.0%

Stay in the know with updates to Enfortumab Vedotin in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.